Kengo Oshima

Kengo Oshima

Auto-generated profile, based on publicly available information

Kengo Oshima

Department of Infectious Diseases, Internal Medicine, Tohoku University Graduate School of Medicine, Sendai 980-8574, Japan

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 November 2007 in Genes to Cells
Verified
Journal Article
Open access
PDF file
YKYukihito Kabuyama
Yukihito Kabuyama
KOKengo Oshima
Kengo Oshima
TKTakuya Kitamura
Takuya Kitamura
MHMiwako Homma
Miwako Homma
JYJunko Yamaki
Junko Yamaki
YHYoshimi Homma
Yoshimi Homma
Idiopathic pulmonary fibrosis (IPF), a chronic progressive lung disease of unknown etiology, is characterized by the expansion of myofibroblasts and abnormal deposition of extracellular matrix in the lung parenchyma. To elucidate the molecular mechanisms that lead to IPF, we analyzed myofibroblasts established from patients with IPF by oligonucleotide microarrays. Gene expression profiles clearly suggested that lipid peroxidation is enhanced in myofibroblasts, which was confirmed by measuring cellular lipid hydroperoxides. One of the most highly up‐regulated proteins in myofibroblasts was selenoprotein P, an antioxidant protein not previously associated with IPF. Subsequent analysis demonstrated that selenoprotein P reduces lipid hydroperoxides and maintains the viability of myofibroblasts. Thus, our results reveal a novel pathophysiologic function of myofibroblasts as a generator of lipid hydroperoxides, and a self‐defense mechanism against self‐generated oxidative stress.

29 January 2023 in Pathogens
Verified
Journal Article
Open access
PDF file
Shiori KitayaShiori Kitaya
Shiori Kitaya
HKHajime Kanamori
Hajime Kanamori
HBHiroaki Baba
Hiroaki Baba
KOKengo Oshima
Kengo Oshima
KTKentarou Takei
Kentarou Takei
KTKoichi Tokuda
Koichi Tokuda
Background: Bloodstream infections (BSIs), including persistent bacteremia (PB), are a leading source of morbidity and mortality globally. PB has a higher mortality rate than non- PB, but the clinical aspects of PB in terms of the causative pathogens and the presence of clearance of PB are not well elucidated. Therefore, this study aimed to describe the clinical and epidemiological characteristics of PB in a real-world clinical setting. Methods: We performed a retrospective observational survey of patients who underwent blood culture between January 2012 and December 2021 at Tohoku University Hospital. Cases of PB were divided into three groups depending on the causative pathogen: gram-positive cocci (GPC), gram-negative rods (GNRs), and Candida spp. For each group, we examined the clinical and epidemiological characteristics of PB, including differences in clinical features depending on the clearance of PB. The main outcome variable was mortality, assessed as early (30-day), late (30–90 day), and 90-day mortality. Results: Overall, we identified 31,591 cases of single bacteremia; in 6709 (21.2%) cases, the first blood culture was positive, and in 3124 (46.6%) cases, a follow-up blood culture (FUBC) was performed. Of the cases with FUBCs, 414 (13.2%) were confirmed to be PB. The proportion of PB cases caused by Candida spp. was significantly higher (29.6%, 67/226 episodes) than that for GPC (11.1%, 220/1974 episodes, p < 0.001) and GNRs (12.1%, 100/824 episodes, p < 0.001). The Candida spp. group also had the highest late (30–90 day) and 90-day mortality rates. In all three pathogen groups, the subgroup without the clearance of PB tended to have a higher mortality rate than the subgroup with clearance. Conclusions: Patients with PB due to Candida spp. have a higher late (30–90 day) and 90-day mortality rate than patients with PB due to GPC or GNRs. In patients with PB, FUBCs and confirming the clearance of PB are useful to improve the survival rate.

16 October 2017 in JMM Case Reports
Verified
Journal Article
Open access
HBHiroaki Baba
Hiroaki Baba
RKRisako Kakuta
Risako Kakuta
HTHasumi Tomita
Hasumi Tomita
MMMinako Miyazoe
Minako Miyazoe
MSMasatoshi Saito
Masatoshi Saito
MKMitsuo Kaku
Mitsuo Kaku
Introduction. This is the first case report of septic abortion due to β-lactamase-negative ampicillin-resistant (BLNAR) non-typeable Haemophilus influenzae infection. In Japan, BLNAR H. influenzae is widespread and has become a clinical concern, especially in paediatrics and otolaryngology, but H. influenzae has not been previously recognized as a causative agent of obstetric or gynaecological infection. Case presentation. A 31-year-old pregnant woman presented at 17 weeks and 6 days of gestation with a high fever; she was admitted with a diagnosis of threatened premature delivery. Despite tocolytic treatment, she aborted spontaneously 2 h after admission and then entered septic shock. BLNAR H. influenzae was detected in both blood and vaginal cultures. Her condition gradually improved after several days of treatment with cefotaxime, and she was ultimately discharged without sequelae or complaints. Conclusion. Although penicillin with a β-lactamase inhibitor is currently recommended for the treatment of septic abortion, this combination will probably lead to treatment failure in the case of BLNAR H. influenzae infection. As this study reveals, H. influenzae can cause septic abortion; hence, future efforts should be undertaken to detect and therapeutically target this pathogen during pregnancy.

1 January 2021 in ERJ Open Research
Verified
Journal Article
Open access
PDF file
KOKengo Oshima
Kengo Oshima
YNYukari Niinuma
Yukari Niinuma
HSHajime Saito
Hajime Saito
HBHiroaki Baba
Hiroaki Baba
HKHajime Kanamori
Hajime Kanamori
MKMitsuo Kaku
Mitsuo Kaku
Mycobacterium marinum can cause pulmonary infection and can grow at ≤32°C. Physicians should consider M. marinum when examining patients with pulmonary infection and low body temperature or anorexia nervosa, and grow the specimen at ≤32°C.https://bit.ly/3jkzBeq

30 September 2023 in Japanese Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
KOKengo Oshima
Kengo Oshima
Human pulmonary dirofilariasis (HPD) is a zoonosis caused by Dirofilaria immitis. Most HPD cases are asymptomatic and are either found on annual health checkups or incidentally identified during investigation of another disease, particularly primary or metastatic pulmonary lung cancer. However, the frequency of Japanese HPD and clinical features remain not well-known. We analyzed data from the Japanese Medical Abstract Society database and identified 69 cases from 1978 to 2022. The incidence of HPD had increased until the 2000s but declined markedly in the 2010s. The incidence was higher in the southwestern and lower in the northeastern region of Japan. Health checkups were the primary diagnostic opportunity. High incidence rates per population were observed in the Chugoku and Shikoku regions. The diagnosis of HPD using a noninvasive procedure is typically difficult due to absence of specific clinical symptoms, and approximately 70% of the cases were detected using video-assisted thoracoscopic surgery. Global warming may increase the incidence of HPD in the northeastern region of Japan, and travel to countries with poor vector control may be a risk factor for HPD transmission. Physicians should consider this parasitic infectious disease when examining patients who present with a solitary nodule in the lungs.

23 December 2021 in Microorganisms
Verified
Journal Article
Open access
PDF file
HBHiroaki Baba
Hiroaki Baba
HKHajime Kanamori
Hajime Kanamori
ISIssei Seike
Issei Seike
INIkumi Niitsuma-Sugaya
Ikumi Niitsuma-Sugaya
KTKentarou Takei
Kentarou Takei
TATetsuji Aoyagi
Tetsuji Aoyagi
Patients with severe Coronavirus disease 2019 (COVID-19) are at high risk for secondary infection with multidrug-resistant organisms (MDROs). Secondary infections contribute to a more severe clinical course and longer intensive care unit (ICU) stays in patients with COVID-19. A man in his 60s was admitted to the ICU at a university hospital for severe COVID-19 pneumonia requiring mechanical ventilation. His respiratory condition worsened further due to persistent bacteremia caused by imipenem-non-susceptible Klebsiella aerogenes and he required VV-ECMO. Subsequently, he developed a catheter-related bloodstream infection (CRBSI) due to Candida albicans, ventilator-associated pneumonia (VAP) due to multidrug-resistant Pseudomonas aeruginosa (MDRP), and a perianal abscess due to carbapenem-resistant K. aerogenes despite infection control procedures that maximized contact precautions and the absence of MDRO contamination in the patient’s room environment. He was decannulated from VV-ECMO after a total of 72 days of ECMO support, and was eventually weaned off ventilator support and discharged from the ICU on day 138. This case highlights the challenges of preventing, diagnosing, and treating multidrug-resistant organisms and healthcare-associated infections (HAIs) in the critical care management of severe COVID-19. In addition to the stringent implementation of infection prevention measures, a high index of suspicion and a careful evaluation of HAIs are required in such patients.